| Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid … JC Byrd, K Mrózek, RK Dodge, AJ Carroll, CG Edwards, DC Arthur, ... Blood, The Journal of the American Society of Hematology 100 (13), 4325-4336, 2002 | 2089 | 2002 |
| Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ... New England journal of medicine 371 (11), 1005-1015, 2014 | 1475 | 2014 |
| Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome AM Wenger, P Peluso, WJ Rowell, PC Chang, RJ Hall, GT Concepcion, ... Nature biotechnology 37 (10), 1155-1162, 2019 | 1294 | 2019 |
| Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. M Smith, D Arthur, B Camitta, AJ Carroll, W Crist, P Gaynon, R Gelber, ... Journal of Clinical Oncology 14 (1), 18-24, 1996 | 1172 | 1996 |
| Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study MJ Borowitz, M Devidas, SP Hunger, WP Bowman, AJ Carroll, WL Carroll, ... Blood, The Journal of the American Society of Hematology 111 (12), 5477-5485, 2008 | 973 | 2008 |
| IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ... Journal of clinical oncology 28 (14), 2348, 2010 | 951 | 2010 |
| Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype CD Bloomfield, D Lawrence, JC Byrd, A Carroll, MJ Pettenati, ... Cancer research 58 (18), 4173-4179, 1998 | 905 | 1998 |
| Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study P Paschka, G Marcucci, AS Ruppert, K Mrózek, H Chen, RA Kittles, ... Journal of Clinical Oncology 24 (24), 3904-3911, 2006 | 855 | 2006 |
| Improved early event-free survival with imatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia: A children's oncology group study KR Schultz, WP Bowman, A Aledo, WB Slayton, H Sather, M Devidas, ... Journal of Clinical Oncology 27 (31), 5175, 2009 | 836 | 2009 |
| Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer … SP Whitman, KJ Archer, L Feng, C Baldus, B Becknell, BD Carlson, ... Cancer research 61 (19), 7233-7239, 2001 | 821 | 2001 |
| The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia Y Liu, J Easton, Y Shao, J Maciaszek, Z Wang, MR Wilkinson, ... Nature genetics 49 (8), 1211-1218, 2017 | 802 | 2017 |
| The genomic landscape of hypodiploid acute lymphoblastic leukemia L Holmfeldt, L Wei, E Diaz-Flores, M Walsh, J Zhang, L Ding, ... Nature genetics 45 (3), 242-252, 2013 | 784 | 2013 |
| Outcome of treatment in children with Philadelphia chromosome–positive acute lymphoblastic leukemia M Aricò, MG Valsecchi, B Camitta, M Schrappe, J Chessells, A Baruchel, ... New England Journal of Medicine 342 (14), 998-1006, 2000 | 754 | 2000 |
| Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia CG Mullighan, JR Collins-Underwood, LAA Phillips, MG Loudin, W Liu, ... Nature genetics 41 (11), 1243-1246, 2009 | 725 | 2009 |
| Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor … RC Harvey, CG Mullighan, IM Chen, W Wharton, FM Mikhail, AJ Carroll, ... Blood, The Journal of the American Society of Hematology 115 (26), 5312-5321, 2010 | 663 | 2010 |
| Risk-and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG … KR Schultz, DJ Pullen, HN Sather, JJ Shuster, M Devidas, MJ Borowitz, ... Blood 109 (3), 926-935, 2007 | 608 | 2007 |
| MicroRNA expression in cytogenetically normal acute myeloid leukemia G Marcucci, MD Radmacher, K Maharry, K Mrózek, AS Ruppert, ... New England Journal of Medicine 358 (18), 1919-1928, 2008 | 539 | 2008 |
| Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia K Mrózek, G Marcucci, D Nicolet, KS Maharry, H Becker, SP Whitman, ... Journal of clinical oncology 30 (36), 4515, 2012 | 525 | 2012 |
| Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031 KR Schultz, A Carroll, NA Heerema, WP Bowman, A Aledo, WB Slayton, ... Leukemia 28 (7), 1467-1471, 2014 | 490 | 2014 |
| Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy … RC Harvey, CG Mullighan, X Wang, KK Dobbin, GS Davidson, EJ Bedrick, ... Blood, The Journal of the American Society of Hematology 116 (23), 4874-4884, 2010 | 455 | 2010 |
